Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Assets

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Assets ₹4,922 Cr₹4,390 Cr₹4,966 Cr₹1,877 Cr₹1,982 Cr

What is the latest Total Non-Current Assets ratio of GLAND PHARMA ?

The latest Total Non-Current Assets ratio of GLAND PHARMA is ₹4,922 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Assets
Mar2026₹4,922 Cr
Mar2025₹4,390 Cr
Mar2024₹4,966 Cr
Mar2023₹1,877 Cr
Mar2022₹1,982 Cr

How is Total Non-Current Assets of GLAND PHARMA Trending?

Years Total Non-Current Assets % Change
Mar2026 ₹4,922 Cr
12.11
Mar2025 ₹4,390 Cr
-11.59
Mar2024 ₹4,966 Cr
164.59
Mar2023 ₹1,877 Cr
-5.29
Mar2022 ₹1,982 Cr -

Compare Total Non-Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,224.6 Cr -1.7% -1.5% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.7%

-1.5%

57.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses